Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study

BACKGROUND: Anti-tuberculosis therapy requires at least six-month treatment with continuous administration of combined antibiotics, including isoniazid, rifampicin, pyrazinamide, and ethambutol. The long-term exposure to antibiotics could cause consequent changes in gut microbiota, which may alter t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wenpei, Hu, Yi, Zheng, Xubin, Ning, Zhu, Wu, Meiying, Xia, Fan, Prast-Nielsen, Stefanie, Hu, Yue O. O., Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849301/
https://www.ncbi.nlm.nih.gov/pubmed/31711450
http://dx.doi.org/10.1186/s12890-019-0981-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849301/
https://www.ncbi.nlm.nih.gov/pubmed/31711450
http://dx.doi.org/10.1186/s12890-019-0981-9

Ejemplares similares